DNLI

Denali Therapeutics Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$20.65

Market Cap

$3.27B

Beta

1.08

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+0.00%

EPS Growth (YoY)-15.56%

Revenue CAGR 3Y+0.00%

P/E Ratio0.0

PEG Ratio—

FCF Yield-12.89%

Debt / Equity0.04

Interest Coverage999.0x

No credit card required

Already have an account? Sign in to view the full analysis for DNLI.